FDA to Hold Two-Day Workshop on Pediatric Safety Studies

CDER and the Office of Pediatric Therapeutics will co-host a two-day public workshop, Advancing the Development of Pediatric Therapeutics: Successes and Challenges of Performing Long-Term Pediatric Safety Studies, April 13 and 14 in Bethesda, Md.

A Federal Register notice on the workshop is available here: www.fdanews.com/03-11-16-Pediatric.pdf.